Keller F, Hasselmann J, Offermann G, Hantelmann W, Molzahn M, Rost A, Maiga M
Int Urol Nephrol. 1983;15(3):281-8. doi: 10.1007/BF02083016.
The important role of immunological factors, HLA typing and pretransplant blood transfusion on improved kidney graft survival is well established. Additionally, graft survival depends on risk factors such as diabetes and age of the recipient. The effect of other clinical risk factors on graft survival was evaluated in 187 patients who received kidney transplants at our centre between 1970 and 1981. Graft survival according to the life table method and statistical analysis according to the logrank test revealed 4 main risk factors. Graft survival is significantly lower in type I diabetics and analgesic nephropathy, whereas it is better in hereditary and other renal diseases. Additional risk factors are coronary heart disease and repeated grafting. Time of dialysis before transplantation and age of the recipient showed no detrimental effect on graft survival.
免疫因素、人类白细胞抗原（HLA）分型及移植前输血对提高肾移植存活率的重要作用已得到充分证实。此外，移植肾的存活还取决于一些危险因素，如糖尿病和受者年龄。1970年至1981年间，我们中心对187例接受肾移植的患者评估了其他临床危险因素对移植肾存活的影响。根据寿命表法得出的移植肾存活率以及根据对数秩检验进行的统计分析揭示了4个主要危险因素。Ⅰ型糖尿病患者和镇痛剂肾病患者的移植肾存活率显著较低，而遗传性及其他肾脏疾病患者的移植肾存活率较高。另外的危险因素是冠心病和再次移植。移植前透析时间和受者年龄对移植肾存活无不利影响。
